Adenosine re-uptake inhibiting derivatives of diphenyl oxazoles,

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

544369, A61K 31495, C07D41306, C07D41706

Patent

active

053825845

ABSTRACT:
A series of 1-piperazinyl-N-phenylacetamide derivatives of 4,5-diphenyl-oxazoles, thiazoles, and imidazoles which are novel adenosine transport inhibitors have been found to provide effective antiischemic protection for CNS and cardiac tissue, particularly neurons. A method of treatment to protect against CNS ischemia, such as that resulting from trauma, stroke, or other ischemic conditions, comprises administration of these novel compounds to an individual in need of such treatment.

REFERENCES:
patent: 3267104 (1966-08-01), Hermans et al.
patent: 4020082 (1977-04-01), Marchetti
patent: 4101660 (1978-07-01), Inoue et al.
patent: 4766125 (1988-08-01), Van Daele
patent: 4948796 (1990-08-01), Hiraiwa et al.
Inoue et al, "2-Aminomethyl-5-phenyloxazoles", Chemical Abstracts, vol. 91 (1979), pp. 707, paragraph: 91:56986x.
Inoue et al, "2-Aminomethyl-5-phenyloxazoles", Chemical Abstracts, vol. 91 (1979), pp. 707-708, paragraph: 91:56987y.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Adenosine re-uptake inhibiting derivatives of diphenyl oxazoles, does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Adenosine re-uptake inhibiting derivatives of diphenyl oxazoles,, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Adenosine re-uptake inhibiting derivatives of diphenyl oxazoles, will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-747227

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.